Doses to the right coronary artery and the left anterior descending coronary artery and death from ischemic heart disease after breast cancer radiotherapy: a case-control study in a population-based cohort

被引:0
|
作者
Perman, Mats [1 ,3 ]
Johansson, Karl -Axel [2 ]
Holmberg, Erik [1 ]
Karlsson, Per [1 ]
机构
[1] Univ Gothenburg, Inst Clin Sci, Sahlgrenska Acad, Dept Oncol, Gothenburg, Sweden
[2] Univ Gothenburg, Inst Clin Sci, Sahlgrenska Acad, Dept Radiat Phys, Gothenburg, Sweden
[3] Sahlgrens Univ Hosp, Dept Oncol, SE-41345 Gothenburg, Sweden
关键词
Breast cancer; cardiotoxicity; coronary arteries; late side-effects; cancer survivorship; RADIATION-THERAPY; MORTALITY; RISK; SURVIVORS; WOMEN; STENOSIS;
D O I
10.2340/1651-226X.2024.19677
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background and purpose: Doses to the coronary arteries in breast cancer (BC) radiotherapy (RT) have been suggested to be a risk predictor of long-term cardiac toxicity after BC treatment. We investigated the dose-risk relationships between near maximum doses (D max ) to the right coronary artery (RCA) and left anterior descending coronary artery (LAD) and ischemic heart disease (IHD) mortality after BC RT. Patients and methods: In a cohort of 2,813 women diagnosed with BC between 1958 and 1992 with a follow-up of at least 10 years, we identified 134 cases of death due to IHD 10-19 years after BC diagnosis. For each case, one control was selected within the cohort matched for age at diagnosis. 3D -volume and 3D -dose reconstructions were obtained from individual RT charts. We estimated the D max the LAD and the mean heart dose (MHD). We performed conditional logistic regression analysis comparing piecewise spline transformation and simple linear modeling for best fit. Results: There was a linear dose-risk relationship for both the D max to the RCA (odds ratio [OR]/Gray [Gy] 1.03 [1.01-1.05]) and the LAD (OR/Gy 1.04 [1.02-1.06]) in a multivariable model. For MHD there was a linear dose-risk relationship (1,14 OR/Gy [1.08-1.19]. For all relationships, simple linear modelling was superior to spline transformations. Interpretation: Doses to both the RCA and LAD are independent risk predictors of long-term cardiotoxicity after RT for BC In addition to the LAD, the RCA should be regarded as an organ at risk in RT planning. to the RCA and
引用
收藏
页码:240 / 247
页数:8
相关论文
共 50 条
  • [1] Left breast radiotherapy - the impact of heart and left anterior descending artery doses to cardiovascular diseases developed eight years after treatment
    Petrovic, Borislava
    Petrovic, Milovan
    Duran, Branislav
    Dan, Igor
    Miljkovic, Tatjana
    Cankovic, Milenko
    Pesznyak, Csilla
    Rutonjski, Laza
    Ivanov, Olivera
    SRPSKI ARHIV ZA CELOKUPNO LEKARSTVO, 2022, 150 (5-6) : 288 - 294
  • [2] Dosimetric Comparison and TCP-NTCP Modeling for Lung, Heart, Left Anterior Descending, and Right Coronary Artery in Left-sided Breast Cancer Conventional and Hypofractionated Radiotherapy
    Taheri, Hossein
    Akhavan, Ali
    Tavakoli, Mohammadbagher
    Moghareabed, Reza
    Kianinia, Mahsa
    INTERNATIONAL JOURNAL OF CANCER MANAGEMENT, 2021, 14 (12)
  • [3] Inter-observer variation in delineation of the heart and left anterior descending coronary artery in radiotherapy for breast cancer: A multi-centre study from Denmark and the UK
    Lorenzen, Ebbe L.
    Taylor, Carolyn W.
    Maraldo, Maja
    Nielsen, Mette H.
    Offersen, Birgitte V.
    Andersen, Maria R.
    O'Dwyer, Dean
    Larsen, Lone
    Duxbury, Sharon
    Jhitta, Baljit
    Darby, Sarah C.
    Ewertz, Marianne
    Brink, Carsten
    RADIOTHERAPY AND ONCOLOGY, 2013, 108 (02) : 254 - 258
  • [4] Development of delineation for. the left anterior descending coronary "artery region in left breast cancer radiotherapy: An optimized organ at risk
    Lee, Jie
    Hua, Kai-Lung
    Hsu, Shih-Ming
    Lin, Jhen-Bin
    Lee, Chou-Hsien
    Lu, Kuo-Wei
    Dai, Kun-Yao
    Huang, Xu-Nian
    Huang, Jun-Zhao
    Wu, Meng-Hao
    Chen, Yu-Jen
    RADIOTHERAPY AND ONCOLOGY, 2017, 122 (03) : 423 - 430
  • [5] Influence of different treatment planning techniques on radiation doses to the heart, left anterior descending coronary artery and left lung in the radiotherapy of left-sided breast cancer patients
    Haddad, P.
    Hadjilooei, F.
    Nedaei, H. A.
    Kalaghchi, B.
    Hashemi, F. Amouzgar
    Farhan, F.
    Babaei, M.
    Esfahani, M.
    Shahriarian, Sh.
    INTERNATIONAL JOURNAL OF RADIATION RESEARCH, 2019, 17 (01): : 119 - 125
  • [6] Detection of a numeric value predictive of increased dose to left anterior descending coronary artery (LAD) in radiotherapy of breast cancer
    Di Franco, R.
    Ravo, V.
    Nieddu, V.
    Crispo, A.
    Falivene, S.
    Giugliano, F. M.
    Argenone, A.
    Borzillo, V.
    Cammarota, F.
    Muto, P.
    SPRINGERPLUS, 2016, 5
  • [7] Cancer Risk from Medical Radiation Procedures for Coronary Artery Disease: A Nationwide Population-based Cohort Study
    Hung, Mao-Chin
    Hwang, Jeng-Jong
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2013, 14 (05) : 2783 - 2787
  • [8] Risk of coronary artery disease after adjuvant radiotherapy in 29,662 early breast cancer patients: A population-based Danish Breast Cancer Group study
    Milo, Marie Louise Holm
    Thorsen, Lise Bech Jellesmark
    Johnsen, Soren Paaske
    Nielsen, Kirsten Melgaard
    Valentin, Jan Brink
    Alsner, Jan
    Offersen, Birgitte Vrou
    RADIOTHERAPY AND ONCOLOGY, 2021, 157 : 106 - 113
  • [9] A generalized model of cardiac surface motion for evaluating left anterior descending coronary artery dose in left breast cancer radiotherapy
    Deng, Yongjin
    Qiu, Minmin
    Li, Yangchan
    Wang, Chaoyang
    Zhong, Jiajian
    Xiao, Zhenhua
    Wang, Chengtao
    Chen, Ruiwan
    MEDICAL PHYSICS, 2024, 51 (10) : 7545 - 7560
  • [10] Long-term risk of ischemic heart disease after adjuvant radiotherapy in breast cancer: results from a large population-based cohort
    Wennstig, Anna-Karin
    Wadsten, Charlotta
    Garmo, Hans
    Fredriksson, Irma
    Blomqvist, Carl
    Holmberg, Lars
    Nilsson, Greger
    Sund, Malin
    BREAST CANCER RESEARCH, 2020, 22 (01)